Solidpharma
ActiveSummary
Solidpharma has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €733,170 and a net result of €163,718. Equity is shrinking by ~3.7% per year across the filed fiscal years. Its solvency ranks better than 45% of 12,456 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Directors
Owners and capital
Owners
1 ownerChain of control
- Namalno
- Solidpharma
Highest known parent: Namalno. The sources do not say who stands above it.
Owners 1
- NamalnoparentSourceaccounts Namalno 2025100%
According to the annual accounts of the companies, the acts in the Belgian Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Companies Code and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.